Chikungunya Virus – An Emerging Threat to the Americas

Presenter(s)

Overview

Chikungunya virus is a mosquito-borne virus that can cause fever and severe polyarthralgia. Outbreaks of the chikungunya have occurred in countries in Africa, Asia, Europe, and the Indian and Pacific Oceans. In late 2013, the first local chikungunya virus transmission in the Americas was reported on islands in the Caribbean. Travelers to areas with ongoing outbreaks are at risk of becoming infected and spreading the virus to new areas, including the United States. During this COCA call, a CDC subject matter expert will provide information on chikungunya virus epidemiology, clinical findings, diagnosis, treatment, and prevention. Additionally, they will describe the importance of early recognition and reporting of suspected cases to mitigate the risk of local transmission.

Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

• Describe which patients to test for the infection
• Explain testing, treatment and prevention measures for chikungunya
• Understand the importance of early recognition and reporting of cases

Call Materials

• Slides:View Now
• Webcast:Watch Now
• Audio:Listen Now
• Transcript:Read Now

Additional Resources

• CDC Health Alert Network (HAN) Notice to Public Health Official and Clinicians: Recognizing, Managing, and Reporting Chikungunya Virus Infections in Travelers Returning from the Caribbean
• CDC Chikungunya Fever
• CDC Chikungunya Information for Healthcare Providers Fact Sheet
• CDC Travelers' Health-Chikungunya

Call Format

• Live webcast and audio conference call on 02/18/14, 2:00 - 3:00 PM
• Web-on-demand training after 3:00 PM on 02/18/14
• Materials: PowerPoint slide set

Additional Call Information

Accreditation Statements

CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME^®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 1.0 contact hour.

IACET CEU:The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 0.1 ANSI/IACET CEU's for this program.

CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number GA0082.

CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-14-075-L04-P and enduring 0387-0000-14-075-H04-P.

This program is knowledge based.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE:In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC does not accept commercial support.